Professional Documents
Culture Documents
From the 1Unit of Cellular Pharmacotoxicology, Centre Hospitalier National dOphtalmologie des Quinze-Vingts, the Toxicology
Laboratory, University of Paris-V; and the 2Ophthalmology and 3Immunohematology Services, Ho
pital Ambroise Pare, Assistance Publique
Ho
pitaux de Paris, University of Paris-V, Boulogne, France.
Submitted for publication August 17, 2000; revised October 27,
2000; accepted November 2, 2000.
Commercial relationships policy: N.
Corresponding author: Christophe Baudouin, Service dOphtalmologie, Ho
pital Ambroise Pare, AP-HP, Universite Paris-V, 9 avenue
Charles de Gaulle, 92104 Boulogne cedex, France.
debbasch@caramail.com
642
MATERIALS
AND
METHODS
Preservative Treatments
Five different preparations of quaternary ammonium molecules were
examined. Three formulations of BAC were tested: (1) C14 benzalkonium chloride, alkyl dimethylbenzylammonium chloride (100%
14-carbon alkyl; BAC100); (2) C14/C12 benzalkonium chloride (58%
14-carbon alkyl; 32% 12-carbon alkyl; BAC58); and (3) C14/C12
benzalkonium chloride (32% 14-carbon alkyl; 58% 12-carbon alkyl;
BAC32). Their antiseptic action is effective at low concentrations
and is due to the hydrocarbon chain length. The maximum activity
is obtained with the C14 molecules and the minimum with the C8
and C18 preservatives.26 In eye drops, the precise composition of
BAC is almost never known, because a mixture of C12 and C14
chains is mostly used. We therefore decided to compare the eventual difference in toxic effects of various preparations of BAC that
have different antiseptic activities.
Benzododecinium bromide (BOB) and cetrimide (Cet) were also
tested. The five quaternary ammoniums were each tested at concentrations of 0.00001%, 0.0001%, 0.001%, 0.005%, and 0.01%, the concentration used in most eye drops being 0.01%.
Five other preservatives were tested at five concentrations: (1)
phenylmercuric nitrate (PM) at concentrations ranging between
0.000001% and 0.001%, its usual concentration being 0.001%; (2)
thimerosal (thi) at concentrations ranging between 0.000004% and
0.004%, usually used at 0.004%; (3) methyl parahydroxybenzoate
(MPHB) at concentrations ranging between 0.00003% and 0.03%, its
usual concentration being 0.03%; (4) chlorobutanol (clb) at concentrations ranging between 0.00005% and 0.05%, its usual concentration
being 0.5%, because high concentrations of this drug are required to
643
produce antimicrobial effects, and we could not obtain this concentration because other excipients are needed to make clb soluble; and
(5) EDTA at concentrations ranging between 0.00001% and 0.01%, the
most common concentration used being 0.01%.
An inhibition study was performed using a 1-hour vitamin E pretreatment followed by a 15-minute BAC 0.001% treatment.
All preservatives and vitamin E were provided by Transphyto,
Clermont-Ferrand, France. All dilutions were realized in culture medium. The complete culture medium was used as a negative control.
Durations of cell treatments with preservatives were chosen as a
compromise between in vitro and in vivo data currently available on
preservatives and in line with our previous work using the same
conjunctival cell line. In vitro, it has been demonstrated that a 100second application of 0.007% BAC produces lysis of 50% of conjunctival cells.27 A 1-hour application of 0.0013% to 0.007% BAC solution
on epithelial corneal cells also produces a 50% decrease in membrane
integrity.28 In vivo, in corneal and conjunctival tissues, BAC has a
half-life of 20 hours for the epithelium and 11 hours for the total
conjunctiva.4
In the present study two incubation times were therefore applied
to control and treated cells: 15 minutes of treatment and 15 minutes
followed by 24 hours of cell recovery in normal culture medium, as
performed in our previous studies.2325 The 24-hour cell recovery
period was also tested as a way of approaching the clinical conditions
in which the conjunctival tissue may recover after eye drop instillation.
Experimental Procedures
Experiments were performed using microplate cold light fluorometry,
which allows fluorometric detection (280 870 nm) with high sensitivity (picograms to femtograms per milliliter) and specificity. Fluorometry was performed with a microplate cytofluorometer29 (Fluorolite
1000; Dynex; Cergy Pontoise, France). According to the recommendations of the European Centre for the Validation of Alternative Methods
(ECVAM), three cellular markers were evaluated: cellular viability,
cellular proliferation, and cellular metabolism with ROS production.30
To complete these results, cell size and DNA content were also
analyzed by flow cytometry. All flow cytometric measurements were
performed on a commercially available flow cytometer (EPICS XL;
Beckman Coulter, Miami, FL) equipped with an argon laser emitting at
488 nm, using software provided by the manufacturer (EPICS XL
system II; Beckman Coulter) for data analysis.
Microplate Cold Light Fluorometry. This new and original
technique allows direct use of numerous fluorescent probes directly
on living cells and allows analysis of 96 wells in less than 1 minute.
Furthermore, each cell sample can be considered sufficiently similar to
the other samples.29 All fluorescent probes were added to live cells, in
mostly physiological conditions, because this method allows detection
of the fluorescent signal directly in the microplate cytofluorometer.
Four different tests were used according to previously validated
methods in a Changs cell line20,22 and other cell systems.31,32 Briefly,
membrane integrity, closely correlated with cellular viability, was evaluated with neutral red (Fluka, Ronkonkoma, NY) using fluorometric
detection (excitation, 535 nm; emission, 600 nm). Neutral red was
used at 50 g/ml. In accordance with the validated protocol of Borenfreund and Puerner,33 200 l per well of medium containing neutral
red was added to living cells, and the microplates were incubated for
3 hours at 37C in atmosphere with 5% CO2. The neutral red fluorescence was measured as previously described.29
H2O2 was detected with the 2,7-dichlorofluorescein diacetate
(DCFH-DA; Molecular Probes, Eugene, OR) dye added to live cells
before any treatment, as previously described.32 This probe is a nonfluorescent cell-permanent compound currently used in flow cytometry that we adapted to microplate cytometry. Once inside the cell, it
is cleaved by endogenous esterases and can no longer pass out of the
cell. The de-esterified product becomes the fluorescent compound
2,7-dichlorofluorescein on oxidation by ROS. The fluorescent signal
detected (excitation, 490 nm; emission, 535 nm) has been demonstrated to be proportional to ROS production.31,32
644
Debbasch et al.
.
O
2 was detected using hydroethidine (Molecular Probes). It was
.
oxidized to the fluorescent ethidium cation by O
2 , allowing the cation
to bind to nuclear DNA with an extensive fluorescent enhancement.34
The probe was used on cells at 5 M after 10 minutes (excitation, 485
nm; emission, 600 nm).
Hoechst 33342 (Molecular Probes) is a specific UV fluorescent
probe (excitation, 360 nm; emission, 450 nm). It specifically reacts
with the DNA, at adenine and thymine levels, by intercalation after 30
minutes.35,36 This probe was used on cells at a final concentration of 10
g/ml. One microliter of propidium iodide (Sigma, St Louis, MO) at 0.5
mg/ml was added to the Hoechst 33342 solution to control necrosis of
cells. In all experiments, the background fluorescence was determined
on wells without cells but containing the dye solution and was deduced from all control and treated wells.
Microplate cold light cytofluorometry results were obtained in
fluorescence units and were expressed as a percentage of the control.
Wells containing cells with complete culture medium but without any
treatment were used as the control. Each drug concentration was
tested in six wells, and each experiment was performed in triplicate.
Statistical comparisons were performed using an analysis of variance
(ANOVA) test to compare the five quaternary ammoniums. The Mann
Whitney test and the z correlation test at a 0.05 level of significance
were also performed (Statview IV for Windows; Abacus, Berkeley, CA).
Flow Cytometric Analysis. Alteration of cell size after preservative treatments was confirmed with flow cytometric analysis of
forward scatter on a linear mode performed 15 minutes after the
treatment. Cells were trypsinized, washed with cold phosphate-buffered saline (PBS), and analyzed for size. At least 3000 cells were
analyzed per sample.
DNA Content. After 15 minutes of treatment, cells were
trypsinized, washed with cold PBS, and fixed 10 minutes with 95%
ethanol in PBS at 20C. Samples were washed with cold PBS, stained
with propidium iodide at room temperature for 20 minutes, and
analyzed on the flow cytometer. The sub-G1 region was determined by
a gate defined in the controls in the whole-cell population, as described
previously.20,37
Immunocytology. In parallel, standard immunofluorescence
was performed to assess morphologic patterns of cells. Cells were
cultured on slides and treated with preservatives for 15 minutes. They
were washed with PBS and fixed as previously described. Phalloidin
(Alexa 488; 200 units/ml, Molecular Probes) was then added to explore
for F-actin. After 30 minutes of incubation, cells were washed in PBS.
Propidium iodide was added to mark cell nuclei before examination
with a confocal epifluorescence microscope (E800 PCM 2000; Nikon,
Tokyo, Japan).
RESULTS
Cellular Viability and Membrane
Integrity Evaluation
Membrane integrity significantly decreased after 15 minutes of
treatment with all the quaternary ammoniums tested (Fig. 1A).
This toxicity appeared at concentrations of 0.005% and 0.01%,
and membrane integrity decreased between 20% and 36% of
the control value (P 0.001 compared with control for all
preservatives). After 24 hours of cell recovery (Fig. 1B), significant cellular damage was found at 0.001% and above. The
same decrease of membrane integrity was observed with
BAC100, BAC58, and BAC32, ranging between 70% with 0.001%
BAC to 30% with 0.01% BAC. With BOB, this decrease varied
from 56% at 0.001% to 32% at 0.01%, and with Cet, it varied
from 57% at 0.001% to 31% at 0.01%. No significant difference
was found when the five quaternary ammoniums were compared using ANOVA.
Clb, EDTA, organomercurials (thi and PM), and MPHB did
not decrease membrane integrity after 15 minutes or after 24
hours of cell recovery for all the concentrations tested (data
645
Control (n 60)
Quaternary ammoniums,
0.005 and 0.01% (n 60)
Chlorobutanol (n 60)
EDTA (n 60)
Organomercurials (n 120)
MPHB (n 60)
15-Minute
Treatment
15-Minute
Treatment
Followed by
24 Hours of
Cell Recovery
100
100
24 4.3*
112 4.3
107 9.5
110 16.3
113 7.5
28 3.8*
97 10.7
92 16.3
91 18.8
101 11.3
Data are expressed as mean percentages of control (SD). Quaternary ammoniums: means of BAC, BOB, and Cet; organomercurials:
means of thi and PM; clb, EDTA, organomercurials, MPHB: means of all
concentrations tested.
* P 0.0001 compared with control and all other preservatives.
No difference between all other preservative groups.
.
FIGURE 4. O
2 production evaluation after 15 minutes of treatment
with quaternary ammoniums. *P 0.001 compared with control.
646
Debbasch et al.
.
FIGURE 5. O
2 production evaluation after 15 minutes of treatment
with preservatives. *P 0.001 compared with control. Key to shading
is in Figure 3.
P 0.0001 for all values). The chromatin condensation observed with clb was less significant (mean fluorescence, 241%,
P 0.05) compared with quaternary ammonium molecules
(Table 2).
DNA Content
We measured sub-G1 cell population after 15 minutes of treatment with the different preservatives. Normal untreated cells
showed a 17% 5% sub-G1 population. The population of
sub-G1 cells was 42% 3%, 54% 7%, and 74% 9% for
0.0001%, 0.001%, and 0.01% quaternary ammonium treatments, respectively (Fig. 9). The other preservatives tested did
not show any significant increase in the apoptotic cell population (sub-G1 population varied from 17% to 23%; data shown
only for MPHB and three concentrations of BAC58).
Morphologic Changes
A concentration-dependent cell retraction was observed after
treatment with quaternary ammoniums molecules, whereas no
morphologic change was observed with the other preservatives tested (Fig. 10).
647
Inhibition Study
No cytotoxicity was observed after a 1-hour vitamin E treatment (Fig. 12). Membrane integrity and chromatin condensation were not altered, compared with complete culture medium alone. No ROS production was detected. After a 1-hour
vitamin E pretreatment followed by a 15-minute BAC 0.001%
treatment, there was no alteration of membrane integrity
(mean fluorescence, 88% with BAC 0.001% versus 120% with a
vitamin E pretreatment followed by a BAC treatment; P
0.001 compared with BAC). Significant decreases in chromatin
.
condensation, H2O2, and O
2 production were observed compared with BAC. However, after a vitamin E pretreatment
followed by a BAC treatment, H2O2 production was increased
(mean fluorescence, 146% with vitamin E with BAC versus
105% with BAC alone; P 0.001 compared with BAC),
.
whereas no significant difference was observed when O
2 productions were compared.
DISCUSSION
Cationic agents are used in pharmaceutical preparations for
antimicrobial preservation because of their ability to lyse miTABLE 2. Chromatin Condensation Evaluations
Control (n 60)
Quaternary ammoniums,
0.005 and 0.01% (n 60)
Clb (n 60)
EDTA (n 60)
Organomercurials (n 120)
MPHB (n 60)
15-Minute
Treatment
15-Minute
Treatment
Followed by
24 Hours of
Cell Recovery
100
100
370 18.2*
162 16.3*
119 10.2
128 18.1
119 18.0
299 19.3*
241 20.7*
121 10.4
118 17.6
117 17.7
crobial cellular membranes. The quaternary ammonium cationic surfactants (BAC, BOB, Cet) we tested have detergent-like
properties that may cause cell damage by emulsification of the
cell wall lipids. Numerous clinical and biologic side effects of
surfactant preservatives have been described, such as ocular
irritation (with lacrimation, hyperemia, photophobia, and
edema), punctate keratitis, gray corneal epithelial haze,
pseudomembrane formation, decreased corneal epithelial microvilli, and cytotoxicity to the corneal epithelial cells.1,2,5 In
addition, cell permeability caused by quaternary ammoniums is
potentiated when EDTA is used. BAC disrupts the bacterial
external membrane, and EDTA disorganizes the cell envelope.38
Organomercurials include thi, phenylmercuric nitrate or
acetate, and mercuric oxide. They bind to the cell membrane
protein sulfhydryl groups, causing an increase in cellular permeability. Adverse ocular side effects due to these preservatives are rare. The most striking side effect is mercurial deposits in various ocular tissues. These compounds have also
induced allergic reactions in sensitized persons; erythema,
edema, and hyperemia of the eyelids; or conjunctivitis. Thi,
however, has been shown to produce cytotoxicity for corneal
epithelial cells.39 44
Clb is mainly known to induce cytotoxicity in corneal epithelial cells. In previous studies, it was reported that occasional
use (twice daily up to 12 days) of a clb-preserved artificial tear
resulted in only modest exfoliation of corneal epithelial cells
(i.e., up to a maximum of 14%).45 These changes were reversible, and it was therefore suggested that the eye could adapt to
repeated use of these preserved artificial tears.46,47
Our results revealed new aspects of preservative toxicity.
After a 15-minute application of all the quaternary ammoniums
tested, membrane integrity of treated cells was altered,
whereas there was no variation of membrane integrity with the
other preservatives. The difference was significant among all
the quaternary ammoniums tested at 0.005% and 0.01% and
among the other preservatives, even at the highest concentrations (P 0.002 compared with quaternary ammoniums).
After a 0.01% quaternary ammonium treatment, cells showed
characteristics of immediate abundant lysis, with membrane
debris and low cell size on flow cytometric analysis graphs.
The effects of all the quaternary ammoniums tested were
progressive. There was a 75% decrease of membrane integrity
648
Debbasch et al.
649
FIGURE 10. F-actin exploration using phalloidin. (A) Control cells and
cells treated with (B) BAC 104%,
(C) BAC 102%, and (D) Cet 102%.
A concentration-dependent decrease
of cell size associated with chromatin
condensation and cell disorganization was observed with quaternary
ammoniums tested at 102%. Magnification, 1000.
FIGURE 12. Evaluation of membrane integrity, chromatin condensation, and ROS production after a 1-hour vitamin E treatment and a
1-hour vitamin E treatment followed by a 15-minute BAC 0.001%
treatment. ***P 0.0001; **P 0.001; *P 0.05 compared with BAC
0.001%.
650
Debbasch et al.
References
1. Gassett AR, Ishii Y, Kaufman HE, Miller T. Cytotoxicity of ophthalmic preservatives. Am J Ophthalmol. 1974;78:98 105.
2. Burstein NL. Preservative cytotoxic threshold for benzalkonium
chloride and chlorhexidine digluconate in cat and rabbit corneas.
Invest Ophthalmol Vis Sci. 1980;32:2259 2265.
3. Burstein NL. The effects of topical drugs and preservatives on the
tears and corneal epithelium in dry eye. Trans Ophthalmol Soc.
1985;104:402 409.
4. Champeau EJ, Edellhauser HF. Effects of ophthalmic preservatives
on the ocular surface: conjunctival and corneal uptake and distribution of benzalkonium chloride and chlorhexidine digluconate.
In: Holly F, Lamberts D, Mac Keen D, ed. The Preocular Tear Film
in Health, Disease, and Contact Lens Wear. TX: Lubbock; 1998:
292302.
5. Gassett AR. Benzalkonium chloride toxicity to the human cornea.
Am J Ophthalmol. 1977;84:169.
6. Fisher AA. Allergic contact dermatitis and conjunctivitis from benzalkonium chloride. Cutis. 1987;39:381383.
7. Goh CL. Contact sensitivity to topical antimicrobials, II: sensitizing
potentials of some topical antimicrobials. Contact Dermatitis.
1989;21:166 171.
8. Baudouin C, Garcher C, Haouat N, Bron A, Gastaud P. Expression
of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma. Ophthalmology. 1994;101:
454 460.
9. Baudouin C, Pisella PJ, Goldschild M, et al. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human
and animal studies. Ophthalmology. 1999;105:556 563.
10. Anders N, Wollensak J. Ocular pseudopemphigoid after topical
drug administration. Klin Monatsbl Augenheilkd. 1994;205:
61 64.
11. Kuppens EV, De Jong CA, Stolwijk TR, De Kreizer RJ, Van Best JA.
Effects of timolol with and without preservative on the basal tear
turnover in glaucoma. Br J Ophthalmol. 1995;79:339 342.
12. Gobbels M, Spitznas M. Corneal epithelial permeability of dry eyes
before and after treatment with artificial tears. Ophthalmology.
1992;99:873 878.
13. Broadway DC, Grierson I, Hitchings RA. Adverse effects of topical
antiglaucomatous medications on the conjunctiva. Br J Ophthalmol. 1993;77:590 596.
14. Broadway DC, Grierson I, OBrien C, Hitchings RA. Adverse effects
of topical antiglaucoma medications, I: the conjunctival cell profile. Arch Ophthalmol. 1994;112:14371445.
15. Lavin MJ, Wormald RPL, Migdal CS, Hitchings RA. The influence of
prior therapy on the success of trabeculectomy. Arch Ophthalmol.
1990;108:15431550.
16. Young TL, Higginbotham EJ, Zou X, Farber MD. Effects of topical
glaucoma drugs on fistulized rabbit conjunctiva. Ophthalmology.
1990;97:14231427.
17. Tripathi BJ, Tripathi RC, Kolli SP. Cytotoxicity of ophthalmic
preservatives on human corneal epithelium. Lens Eye Toxicity Res.
1992;9:361375.
18. Samples JR, Binder S, Nayak S. The effects of epinephrine and
benzalkonium chloride on cultured corneal and trabecular meshwork cells. Exp Eye Res. 1989;49:112.
19. Shaw AJ, Balls M, Clothier RH, Bateman ND. Predicting ocular
irritancy and recovery from injury using Madin-Darby canine kidney cells. Toxicol In Vitro. 1991;5:169 174.
20. Takahashi N. Cytotoxicity of mercurial preservatives in cell culture. Ophthalmic Res. 1982;14:63 69.
21. De Saint Jean M, Brignole F, Bringuier AF, Bauchet A, Feldmann G,
Baudouin C. Effects of benzalkonium chloride on growth and
survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci.
1999;40:619 630.
22. Debbasch C, De Saint Jean M, Pisella PJ, Rat P, Warnet JM, Baudouin C. Influence of preservatives on conjunctival cells in vitro. J
Toxicol Cutan Ocul Toxicol. 2000,19:79 88.
23. Debbasch C, De Saint Jean M, Pisella PJ, Rat P, Warnet JM, Baudouin C. Evaluation of toxicity of preservative-free and preserved
beta-blockers in a human conjunctival cell line [ARVO abstract].
Invest Ophthalmol Vis Sci. 1999;40(4):S825. Abstract nr 4348.
651
24. Debbasch C, De Saint Jean M, Pisella PJ, Rat P, Warnet JM, Baudouin C. Cytotoxicite des ammoniums quaternaires sur une lignee
de cellules conjonctivales humaines. J Fr Ophtalmol. 1999;22:
950 958.
25. De Saint Jean M, Debbasch C, Brignole F, Rat P, Warnet JM,
Baudouin C. Toxicity of preserved and unpreserved antiglaucoma
topical drugs in an in vitro model of conjunctival cells. Curr Eye
Res. 2000;20:8594.
26. Fleurette J, Freney J, Reverdy ME. Les ammoniums quaternaires. In:
Eska, ed. Antisepsie et Desinfection. Paris, France: Alexandre
Lacassagne; 1996:174 198.
27. Takahashi N. Quantitative cytotoxicity of preservatives evaluated
in cell culture with Changs human conjunctival cells: effects of
temperature on cytotoxicity. Jpn J Ophthalmol. 1982;26:234 238.
28. Grant RL, Acosta D. Prolonged adverse effects of benzalkonium
chloride and sodium dodecyl sulfate in a primary culture system of
rabbit corneal epithelial cells. Fundam Appl Toxicol. 1996;33:
71 82.
29. Rat P, KorwinZmilowska C, Warnet J-M, Adolphe M. New in vitro
fluorimetric microtitration assays for toxicological screening of
drugs. Cell Biol Toxicol. 1994;10:329 337.
30. Balls M, Fentem J-H. The use of basal cytotoxicity and target organ
toxicity tests in hazard identification and risk assessment. Alternatives to Laboratory Animals. 1992;20:368 388.
31. Rat P, Osseni R, Christen MO, Thevenin M, Warnet J-M, Adolphe
M. Microtitration fluorimetric assays on living cells (MiFALC tests):
new tools for screening in cell pharmacotoxicology. In: Van Zutphen LFM, Balls M, eds. Animal Alternatives, Welfare and Ethics.
Paris: Elsevier; 1997:813 825.
32. Osseni RA, Debbasch C, Christen MO, Rat P, Warnet JM. Tacrineinduced reactive oxygen species in a human liver cell line: the role
of anethole dithiolethione as a scavenger. Toxicol In Vitro. 1999;
13:683 688.
33. Borenfreund E, Puerner JA. A simple quantitative procedure using
monolayer cultures for cytotoxicity assays (HTD/NR-90). J Tissue
Cult Methods. 1984;9:79.
34. Budd SL, Castilho RF, Nicholls DG. Mitochondrial membrane potential and hydroethidine-monitored superoxide generation in cultured cerebellar granule cells. FEBS Lett. 1997;415:2124.
35. Belloc F, Dumain P, Boisseau MR, et al. A flow cytometric method
using Hoechst 33342 and propidium iodide for simultaneous cell
cycle and apoptosis determination in unfixed cells. Cytometry.
1994;17:59 65.
36. Rat P, Osseni R, Toure S, et al. Microtitration fluorimetric assays on
alive cells (MiFAAC tests) used for tacrine cytotoxicity evaluation.
Cell Biol Toxicol. 1996;S1:38.
37. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C. A
rapid and simple method for measuring thymocyte apoptosis by
propidium iodide staining and flow cytometry. J Immunol Methods. 1991;139:271279.
38. Van Ooteghem M. Les collyres guttae ophthalmicae. In: Van Ooteghem M, ed. Preparations Ophtalmiques. Technique et Documentation. Paris, France; Lavoisier; 1995:58 110.
39. Chiou GCY. Ophthalmic Toxicology. New York: Raven Press;
1992:232260.
40. Fraunfelder FT. Drug-Induced Ocular Side Effects and Drug Interactions. 2nd ed. Philadelphia: Lea & Febiger; 1982:364 372.
41. Grant WM. Toxicology of the Eye. 3rd ed. Springfield, IL: Charles
C. Thomas; 1986.
42. Collin HB. Ultrastructural changes to corneal stromal cells due to
ophthalmic preservatives. Acta Ophthalmol. 1986;64:7278.
43. Wantke F. Thimerosal induces toxic reactions. Int Arch Allergy
Immunol. 1994;105:408.
44. Van Horn DL, Edelhauser HF, Prodanovich G, Eiferman R, Pederson HF. Effect of the ophthalmic preservative thimerosal on rabbit
and human corneal endothelium. Invest Ophthalmol Vis Sci. 1977;
16:273280.
45. Nordt SP. Chlorobutanol toxicity. Ann Pharmacother. 1996;30:
1179 80.
46. Doughty MJ. Twice-daily use of a chlorobutanol-preserved artificial
tear on rabbit corneal epithelium assessed by scanning electron
microscopy. Ophthalmic Physiol Opt. 1992;12:457 466.
652
Debbasch et al.